These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 18765248

  • 1. Old mice present increased levels of succinate dehydrogenase activity and lower vulnerability to dyskinetic effects of 3-nitropropionic acid.
    Rosenstock TR, Abílio VC, Frussa-Filho R, Kiyomoto BH, Smaili SS.
    Pharmacol Biochem Behav; 2009 Jan; 91(3):327-32. PubMed ID: 18765248
    [Abstract] [Full Text] [Related]

  • 2. 3-nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions.
    Mirandola SR, Melo DR, Saito A, Castilho RF.
    J Neurosci Res; 2010 Feb 15; 88(3):630-9. PubMed ID: 19795369
    [Abstract] [Full Text] [Related]

  • 3. Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid.
    Dautry C, Condé F, Brouillet E, Mittoux V, Beal MF, Bloch G, Hantraye P.
    Neurobiol Dis; 1999 Aug 15; 6(4):259-68. PubMed ID: 10448053
    [Abstract] [Full Text] [Related]

  • 4. Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice.
    Alexi T, Hughes PE, Knüsel B, Tobin AJ.
    Exp Neurol; 1998 Sep 15; 153(1):74-93. PubMed ID: 9743569
    [Abstract] [Full Text] [Related]

  • 5. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
    Túnez I, Collado JA, Medina FJ, Peña J, Del C Muñoz M, Jimena I, Franco F, Rueda I, Feijóo M, Muntané J, Montilla P.
    Neurochem Int; 2006 Apr 15; 48(5):367-73. PubMed ID: 16420966
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of transcranial magnetic stimulation on oxidative stress induced by 3-nitropropionic acid in cortical synaptosomes.
    Túnez I, Montilla P, del Carmen Muñoz M, Medina FJ, Drucker-Colín R.
    Neurosci Res; 2006 Sep 15; 56(1):91-5. PubMed ID: 16837092
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of nicotine on 3-nitropropionic acid-induced oxidative stress in synaptosomes.
    Túnez I, Montilla P, Muñoz MC, Drucker-Colín R.
    Eur J Pharmacol; 2004 Nov 19; 504(3):169-75. PubMed ID: 15541418
    [Abstract] [Full Text] [Related]

  • 13. Effect of glucocorticoids on 3-nitropropionic acid-induced oxidative stress in synaptosomes.
    Montilla P, Túnez I, Muñoz MC, Salcedo M, Feijóo M, Muñoz-Castañeda JR, Bujalance I.
    Eur J Pharmacol; 2004 Mar 19; 488(1-3):19-25. PubMed ID: 15044031
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.
    Brouillet E, Guyot MC, Mittoux V, Altairac S, Condé F, Palfi S, Hantraye P.
    J Neurochem; 1998 Feb 19; 70(2):794-805. PubMed ID: 9453576
    [Abstract] [Full Text] [Related]

  • 16. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
    Lee ST, Park JE, Kim DH, Kim S, Im WS, Kang L, Jung SH, Kim MW, Chu K, Kim M.
    Brain Res; 2008 Feb 15; 1194():130-7. PubMed ID: 18166168
    [Abstract] [Full Text] [Related]

  • 17. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P, Kumar A.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):91-101. PubMed ID: 19445928
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington's disease.
    Túnez I, Drucker-Colín R, Jimena I, Medina FJ, Muñoz Mdel C, Peña J, Montilla P.
    J Neurochem; 2006 May 01; 97(3):619-30. PubMed ID: 16524377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.